About Flexion Therapeutics
Flexion Therapeutics is a Healthcare company based in Woburn (United States) founded in 2007, and was acquired by Pacira in October 2021. Flexion Therapeutics has raised $62 million across 4 funding rounds from investors including Pfizer, Pacira and 5AM Ventures. The company has 692 employees. Its focus areas include Life Sciences, Pain Management, Drugs and Diversified. Its competitors include Formation Bio, Eliem Therapeutics and Zogenix; 3 of its 3 listed competitors have raised funding.
Company details
Developer of therapies for the treatment of musculoskeletal disorders. The company is currently advancing a portfolio of injectable drug candidates that have the potential to provide better and more persistent analgesia compared with existing therapies. Their lead program, FX006, is an intra-articular sustained-release steroid injectable for patients with moderate to severe osteoarthritis (OA) pain. They also have two additional product candidates FX007, a locally administered TrkA receptor antagonist for post-operative pain, and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor for end-stage OA patients.
- Headquarters Woburn, United States
- Employees 692
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website flexiontherapeutics.com
- Social LinkedIn X Facebook
- Acquired by Pacira (Oct 2021)
- Annual Revenue$85.55 M (USD)17as on Dec 31, 2020
- Net Profit-$113.71 M (USD)24as on Dec 31, 2020
- EBITDA-$93.02 M (USD)32as on Dec 31, 2020
- Total Equity Funding$62M (USD)
in 4 rounds
- Latest Funding Round$175M (USD), Post-IPO
May 2017
- InvestorsPfizer
& 6 more
- Employee Count692
- Acquired byPacira
(Oct 2021)
Funding Insights of Flexion Therapeutics
Flexion Therapeutics has successfully raised a total of $62M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $175 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $62M
- Total Rounds 4
- Last Round Post-IPO β $175M
- First Round $42M
(Oct 2009)
- Investors Count 6
All 4 funding rounds of Flexion Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2017 | $175M | Post-IPO | β | β | β |
| Apr 2017 | $201.3M | Post-IPO | β | β | β |
| Dec 2012 | $20M | Series B | β | Novo Holdings | |
| Oct 2009 | $42M | Series A | β | Versant Ventures |
7 investors in total: 7 institutional.
Investors in Flexion Therapeutics
Flexion Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, Pacira and 5AM Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed incubator focused on the healthcare startups | 5amventures.com | San Francisco, United States | ||
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999. | versantventures.com | |||
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark | ||
Venture capital is focused on healthcare by Pfizer's investment arm. | pfizer.com/partnering/areas_of_interest/venture_investments | New York, United States | ||
Sofinnova Partners is focused on life sciences and healthcare investments. | sofinnovapartners.com | Paris, France | ||
Pharmaceutical products for treating multiple diseases are provided. | 1849 | pfizer.com | New York, United States | |
Injectable non-opioid products for post-surgical pain control are developed. | 2006 | pacira.com | Parsippany Troy Hills, United States |
Investor details for Flexion Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Flexion Therapeutics
283 people are tracked at Flexion Therapeutics (147 in leadership, 10 in board & advisors, 126 in team); the tracked headcount is 692.
| Name | Role | Group |
|---|---|---|
Tyler Jones | Area Director Of Sales-west | Leadership |
Bryan Darge | Associate Director Market Access & Reimbursement | Leadership |
Sara Ghazaii Marino | Executive Director, Head Of Corporate Communications | Leadership |
Leanna B. | Director, Sales Operations | Leadership |
Susan Mesco | Vice President Investor Relations | Leadership |
Rosanne Atencio | Executive Director | Leadership |
Steven Savage | Associate Director, Corporate Accounting | Leadership |
Jonathan Slonin | Chief Medical Officer | Leadership |
Maksim N. | Executive Director Of Corporate And Business Development | Leadership |
Peter Hefti Cma, Cpa | Director - Science Center Campus Controller | Leadership |
Jeremy Grubb | Regional Business Director | Leadership |
Jillian Mangiro Phr | Senior Director, HR Business Partner | Leadership |
Alex Celius | Director, Compliance | Leadership |
Ebenezer Egyepong | Associate Director | Leadership |
Scott Daul | Senior Director Of Market Access - Reimbursement | Leadership |
David Cochran | Director IT Project Management | Leadership |
Chad Brightwell | Regional Sales Director | Leadership |
Jared Ham Pharmd, Bcps, Bcccp | Medical Science Liaison, Director | Leadership |
Stan Dysart M.D., Mba, Faaos | Vice President Medical Affairs, Orthopaedics | Leadership |
William L. Lanzer | Sr Director Medical Affairs - Orthopedic Specialty Group | Leadership |
263 more people are available in the full profile.
Complete people profiles for Flexion Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Flexion Therapeutics
5 dated milestones of Flexion Therapeutics across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Flexion Therapeutics is founded.
- Funding First funding round of $42.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $175.0M.
- Exit Acquired by Pacira.
Competitors of Flexion Therapeutics
Flexion Therapeutics has 3 listed competitors in our database, 3 of them funded. They include Formation Bio, Eliem Therapeutics and Zogenix.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| formation.bio | 2016 | New York, United States | $608.25M | AI-powered drug discovery platform for various diseases | ||
| eliemtx.com | 2018 | Boston, United States | $171.3M | 30 | Develops antibody-based treatments for autoimmune and inflammatory disorders. | |
| zogenix.com | 2006 | Emeryville, United States | $149.06M | 159 | Drug delivery systems for CNS disorders and pain are developed. |
Detailed competitors of Flexion Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Flexion Therapeutics
Websites that share an audience with Flexion Therapeutics (flexiontherapeutics.com).
Websites whose visitors overlap most with Flexion Therapeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| concertpharma.com | 100% | View details | |||
elevenbio.com | elevenbio.com | 91% | β | ||
| auspexpharma.com | 83% | View details | |||
| alderbio.com | 82% | View details | |||
| arenapharm.com | 82% | View details | |||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 13 similar websites and full traffic analytics for Flexion Therapeutics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as Flexion Therapeutics (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Flexion Therapeutics
Complete news archive for Flexion Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Flexion Therapeutics
Flexion Therapeutics was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Flexion Therapeutics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Flexion Therapeutics is a funded company, having raised a total of $62M across 4 funding rounds to date. The company's 1st funding round was a Series A of $42M, raised on Oct 2009.
Flexion Therapeutics has 692 employees.
Annual revenue of Flexion Therapeutics is $85.55M as on Dec 31, 2020.
Developer of therapies for the treatment of musculoskeletal disorders. The company is currently advancing a portfolio of injectable drug candidates that have the potential to provide better and more persistent analgesia compared with existing therapies. Their lead program, FX006, is an intra-articular sustained-release steroid injectable for patients with moderate to severe osteoarthritis (OA) pain. They also have two additional product candidates FX007, a locally administered TrkA receptor antagonist for post-operative pain, and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor for end-stage OA patients.
Flexion Therapeutics's top competitors include Formation Bio, Zogenix and Eliem Therapeutics.
Flexion Therapeutics has 7 investors. Key investors include Pfizer, Pacira, 5AM Ventures, Versant Ventures, and Novo Holdings.
Yes. Flexion Therapeutics was acquired by Pacira in October 2021.

